European Organisation for
Research and Treatment of Cancer

Active for
60 years

Network of
3400+ scientists

Present in
50 countries

100+ studies
in follow-up

40+ ongoing

260+ experts
in HQ

Latest news

  • EORTC Quality of Life measures integrated in CDISC

    EORTC Quality of Life measures integrated in CDISC

  • ATOM study

    EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

  • acute myeloid leukaemia publication

    Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

Latest publications

Upcoming events

  • EORTC Y-ECI QLG/LCG First Collaborative Webinar

  • BGICC 2024

    Breast Gynecological & Immunooncology International Cancer Conference


  • Past events

  • EORTC Gynecological cancer group

    EORTC Gynecological Cancer Group Autumn Meeting

    Brussels, Belgium (hybrid)

  • ECI Leadership Programme

    Y-ECI LCG and Y-ECI ROSC Webinar – Session 2


  • Highlights

    • Annual-Report-2022

      Publication of 2022 EORTC Annual Report

    • Manifesto - Illustration


    • EORTC Practice Changing Trials

      Practice Changing Trials

    • EORTC Cancer Research Fund


      EORTC Cancer Research Fund